BIOHAVEN PHARMACTL HLDG CO L's ticker is and the CUSIP is G11196905. A total of 7 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,063,000 | +315.2% | 124 | +254.3% | 0.04% | +122.2% |
| Q2 2020 | $256,000 | -79.3% | 35 | -90.4% | 0.02% | -82.5% |
| Q1 2020 | $1,239,000 | -40.7% | 364 | -5.2% | 0.10% | -43.4% |
| Q4 2019 | $2,090,000 | -25.3% | 384 | -42.8% | 0.18% | -29.2% |
| Q3 2019 | $2,799,000 | -24.7% | 671 | -21.0% | 0.26% | -24.0% |
| Q2 2019 | $3,718,000 | +65.3% | 849 | +94.3% | 0.34% | +55.0% |
| Q1 2019 | $2,249,000 | +119.8% | 437 | +10.1% | 0.22% | +80.2% |
| Q1 2018 | $1,023,000 | +143.0% | 397 | +154.5% | 0.12% | +95.2% |
| Q4 2017 | $421,000 | -59.9% | 156 | -44.5% | 0.06% | -64.6% |
| Q3 2017 | $1,050,000 | – | 281 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 53 | $454,000 | 0.09% |
| BOOTHBAY FUND MANAGEMENT, LLC | 124 | $1,063,000 | 0.04% |
| Hudson Bay Capital Management LP | 70,000 | $6,000,000 | 0.03% |
| GROUP ONE TRADING, L.P. | 63,500 | $5,443,000 | 0.01% |
| JPMORGAN CHASE & CO | 543,100 | $46,549,000 | 0.01% |
| SIMPLEX TRADING, LLC | 202 | $1,731,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |